TwinEdge Bioscience
Where to find us at Bits & Pretzels

European Pitch Contest, Top50

Key Facts

Company Description

TwinEdge Bioscience is a techbio company dedicated to the development of Digital Twins for oncology drug discovery and development. Combining computational biology, AI, and personalized medicine, TwinEdge is transforming how new cancer therapies are developed by delivering population scale insight throughout the drug development process.

Product/Service Description

TwinEdge is creating the world’s largest population of oncology Digital Twins, digitally actionable representations of patients’ tumours, ready for testing with new drugs in “in-silico” trials.

Crunchbase

Country

Switzerland

Founding Year

2025

Employees

< 5

Company Stage

First Pilot Customers

Business Model

B2B

Focus Industries

Healthcare

Active Markets

(5 most relevant ones)

US, UK, Switzerland, Germany, China

Look for at Bits & Pretzels

Investors
Network
Visibility

Funding & Investors

3 Lead Investors

Capital Raised to Date

Last Funding Type

Pre-Seed

Last Funding Date

Capital Need (€)

5-15M

Currently Fundraising

(at the time of  Bits & Pretzels 2025)

Yes

Growth Outlook

Traction

Monetization Model

3 Reference Customers

Revenues 2024

Planned Revenues 2025

Planned Revenues 2026

Target Markets

(within 24 months)

Benelux
Nordics
North America
Western Europe

Team

Mike Prosser

CEO

mike.prosser@twinedgebio.com